Cross Country Healthcare's stock performance suggests investors expect a challenging period for the company. Long-term tailwinds include high capital turnover, compounding earnings, compressed ...
Cross Country Healthcare offers a compelling merger-arbitrage opportunity with a potential 60% upside if the Aya Healthcare acquisition closes at $18.61 per share. Despite FTC scrutiny and a Second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results